Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 9 studies | 37% ± 18% | |
pericyte | 8 studies | 43% ± 19% | |
smooth muscle cell | 6 studies | 31% ± 14% | |
adipocyte | 5 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1715.83 | 650 / 653 | 71% | 2.45 | 430 / 605 |
breast | 99% | 2065.90 | 456 / 459 | 67% | 1.84 | 751 / 1118 |
adipose | 100% | 3843.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1489.90 | 854 / 861 | 0% | 0 | 0 / 0 |
muscle | 92% | 668.61 | 740 / 803 | 0% | 0 | 0 / 0 |
skin | 54% | 523.64 | 971 / 1809 | 28% | 1.33 | 131 / 472 |
blood vessel | 80% | 1046.25 | 1068 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 60% | 549.71 | 872 / 1445 | 14% | 0.26 | 25 / 183 |
kidney | 3% | 38.58 | 3 / 89 | 62% | 5.66 | 561 / 901 |
pancreas | 5% | 20.51 | 17 / 328 | 60% | 2.09 | 107 / 178 |
prostate | 11% | 85.66 | 26 / 245 | 55% | 1.83 | 274 / 502 |
bladder | 57% | 418.86 | 12 / 21 | 8% | 0.14 | 38 / 504 |
adrenal gland | 5% | 35.90 | 13 / 258 | 45% | 1.64 | 104 / 230 |
intestine | 34% | 209.14 | 325 / 966 | 12% | 0.52 | 62 / 527 |
uterus | 36% | 223.87 | 61 / 170 | 9% | 0.53 | 40 / 459 |
stomach | 23% | 145.86 | 81 / 359 | 21% | 0.61 | 61 / 286 |
lung | 9% | 55.68 | 54 / 578 | 13% | 0.29 | 149 / 1155 |
ovary | 11% | 217.82 | 19 / 180 | 6% | 0.15 | 24 / 430 |
brain | 3% | 18.96 | 84 / 2642 | 11% | 0.50 | 75 / 705 |
liver | 0% | 0 | 0 / 226 | 12% | 0.20 | 48 / 406 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.05 | 2 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050873 | Biological process | brown fat cell differentiation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0060612 | Biological process | adipose tissue development |
GO_0001709 | Biological process | cell fate determination |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | EBF2 |
Protein name | EBF2 protein Transcription factor COE2 (Early B-cell factor 2) (EBF-2) EBF transcription factor 2 (cDNA FLJ55302, highly similar to Transcription factor COE2) |
Synonyms | COE2 |
Description | FUNCTION: Transcription factor that, in osteoblasts, activates the decoy receptor for RANKL, TNFRSF11B, which in turn regulates osteoclast differentiation. Acts in synergy with the Wnt-responsive LEF1/CTNNB1 pathway. Recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3' (By similarity). . |
Accessions | Q9HAK2 ENST00000520164.6 [Q9HAK2-1] ENST00000535548.1 [Q9HAK2-2] B7Z934 ENST00000408929.7 B2RNT0 |